Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 182.80
-6.50 (-3.43%)
At close: Jun 8, 2026
HKG:2637 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 177.03 | 136.08 | 117.45 | 68.98 |
Depreciation & Amortization | 7.72 | 4.98 | 3.89 | 2.81 |
Loss (Gain) From Sale of Assets | 0.15 | - | 0.03 | 0.02 |
Loss (Gain) From Sale of Investments | -6.66 | -1.14 | - | 0.14 |
Stock-Based Compensation | - | 0 | 0.01 | 0.03 |
Provision & Write-off of Bad Debts | -0.01 | 0.13 | 0.67 | -0.06 |
Other Operating Activities | 13.34 | 15.4 | 23.24 | 29.24 |
Change in Accounts Receivable | -21.83 | -22.78 | -25.47 | 5.62 |
Change in Inventory | -21.08 | -10.41 | 3.4 | -5.54 |
Change in Accounts Payable | 17.35 | 33.9 | 25.61 | -13.2 |
Change in Unearned Revenue | -6.13 | 7.78 | -1.72 | -2.73 |
Operating Cash Flow | 159.88 | 163.94 | 147.11 | 85.31 |
Operating Cash Flow Growth | -2.48% | 11.45% | 72.44% | - |
Capital Expenditures | -44.79 | -178.56 | -58.71 | -3.07 |
Sale (Purchase) of Intangibles | -0.13 | - | - | - |
Sale (Purchase) of Real Estate | - | - | -0.78 | -28.63 |
Investment in Securities | -441.4 | -244.13 | 100.42 | -22.04 |
Other Investing Activities | 7.08 | 43.98 | -53.69 | -0.02 |
Investing Cash Flow | -479.24 | -378.72 | -12.77 | -53.76 |
Long-Term Debt Issued | 78.51 | 17.83 | 5.57 | - |
Long-Term Debt Repaid | -9.63 | -4.83 | -46.91 | -9.84 |
Net Debt Issued (Repaid) | 68.88 | 13 | -41.34 | -9.84 |
Issuance of Common Stock | 907.92 | - | - | 157.6 |
Other Financing Activities | -45.79 | -14.27 | -10.15 | -14.63 |
Financing Cash Flow | 931.01 | -1.27 | -51.49 | 133.13 |
Foreign Exchange Rate Adjustments | -4.88 | - | - | - |
Net Cash Flow | 606.77 | -216.04 | 82.85 | 164.68 |
Free Cash Flow | 115.09 | -14.62 | 88.39 | 82.24 |
Free Cash Flow Growth | - | - | 7.47% | - |
Free Cash Flow Margin | 19.76% | -3.13% | 27.92% | 38.71% |
Free Cash Flow Per Share | 1.66 | -0.22 | 1.31 | 1.28 |
Cash Interest Paid | 14.26 | 13.43 | 10.15 | 14.63 |
Cash Income Tax Paid | 15.83 | 4.28 | 0.01 | - |
Levered Free Cash Flow | 27.61 | -57.3 | 59.52 | - |
Unlevered Free Cash Flow | 31.2 | -52.79 | 64.36 | - |
Change in Working Capital | -31.69 | 8.5 | 1.81 | -15.85 |